This 185-page report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for tumor markers technologies. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.
The report also presents strategic assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
Contains 185 pages
SIMILAR MARKET STUDIES
This report studies sales (consumption) of Self Healing Materials in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Owens Coring Johns Manville Dow Cytec ...
July 2016 | $4000 | View Details >>
Notes: Production, means the output of Diagnostic Imaging Revenue, means the sales value of Diagnostic Imaging This report studies Diagnostic Imaging in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering ...
October 2016 | $2900 | View Details >>
2015 European Hematology and Flow Cytometry Markets: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies, Opportunities for Suppliers - France, Germany, Italy, Spain, UK Summary This comprehensive five-country report Contains 450 pages, 160 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the European hematology and flow cytometry markets during the next five years.
January 2015 | $12800 | View Details >>
The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.This new study from Venture Planning Group contains 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.
July 2014 | $1200 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research